Early drug development predictions of glass-forming ability and physical stability of drugs

The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A series of 50 structurally diverse drug molecules were studied with respect to glass-forming ability and, for glass-formers (n=24), the physi...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmaceutical sciences Vol. 49; no. 2; pp. 323 - 332
Main Authors: Mahlin, Denny, Bergström, Christel A.S.
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 13-05-2013
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A series of 50 structurally diverse drug molecules were studied with respect to glass-forming ability and, for glass-formers (n=24), the physical stability upon 1month of storage was determined. Spray-drying and melt-cooling were used to produce the amorphous material and the solid state was analysed by Differential Scanning Calorimetry (DSC) and Powder X-ray Diffraction. Thermal properties and molecular weight (Mw) were used to develop predictive models of (i) glass-forming ability and (ii) physical stability. In total, the glass-forming ability was correctly predicted for 90% of the drugs from their Mw alone. As a rule of thumb, drugs with Mw greater than 300g/mole are expected to be transformed to its amorphous state by using standard process technology. Glass transition temperature and Mw predicted the physical stability upon storage correctly for 78% of the glass-forming compounds. A strong sigmoidal relationship (R2 of 0.96) was identified between crystallization temperature and stability. These findings have the potential to rationalize decisions schemes for utilizing and developing amorphous formulations, through early predictions of glass-forming ability from Mw and physical stability from simple DSC characterization.
AbstractList The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A series of 50 structurally diverse drug molecules were studied with respect to glass-forming ability and, for glass-formers (n=24), the physical stability upon 1 month of storage was determined. Spray-drying and melt-cooling were used to produce the amorphous material and the solid state was analysed by Differential Scanning Calorimetry (DSC) and Powder X-ray Diffraction. Thermal properties and molecular weight (Mw) were used to develop predictive models of (i) glass-forming ability and (ii) physical stability. In total, the glass-forming ability was correctly predicted for 90% of the drugs from their Mw alone. As a rule of thumb, drugs with Mw greater than 300 g/mole are expected to be transformed to its amorphous state by using standard process technology. Glass transition temperature and Mw predicted the physical stability upon storage correctly for 78% of the glass-forming compounds. A strong sigmoidal relationship (R(2) of 0.96) was identified between crystallization temperature and stability. These findings have the potential to rationalize decisions schemes for utilizing and developing amorphous formulations, through early predictions of glass-forming ability from Mw and physical stability from simple DSC characterization.
The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A series of 50 structurally diverse drug molecules were studied with respect to glass-forming ability and, for glass-formers (n=24), the physical stability upon 1month of storage was determined. Spray-drying and melt-cooling were used to produce the amorphous material and the solid state was analysed by Differential Scanning Calorimetry (DSC) and Powder X-ray Diffraction. Thermal properties and molecular weight (Mw) were used to develop predictive models of (i) glass-forming ability and (ii) physical stability. In total, the glass-forming ability was correctly predicted for 90% of the drugs from their Mw alone. As a rule of thumb, drugs with Mw greater than 300g/mole are expected to be transformed to its amorphous state by using standard process technology. Glass transition temperature and Mw predicted the physical stability upon storage correctly for 78% of the glass-forming compounds. A strong sigmoidal relationship (R2 of 0.96) was identified between crystallization temperature and stability. These findings have the potential to rationalize decisions schemes for utilizing and developing amorphous formulations, through early predictions of glass-forming ability from Mw and physical stability from simple DSC characterization.
Author Bergström, Christel A.S.
Mahlin, Denny
Author_xml – sequence: 1
  givenname: Denny
  surname: Mahlin
  fullname: Mahlin, Denny
  email: denny.mahlin@farmaci.uu.se
  organization: Department of Pharmacy, Uppsala University, Uppsala, Sweden
– sequence: 2
  givenname: Christel A.S.
  surname: Bergström
  fullname: Bergström, Christel A.S.
  organization: Department of Pharmacy, Uppsala University, Uppsala, Sweden
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23557841$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-204132$$DView record from Swedish Publication Index
BookMark eNp9kcFu1DAQhi1URLeFF-CAfORAlrGdOLbEpSqlRarEBbhwsBx7sniVxMFOivbt8WrbHpFGGmn0zXf4_wtyNsUJCXnLYMuAyY_7Le7nvOXAxBbKMPmCbJhqdQUthzOyAc1VBVq15-Qi5z0ASNXCK3LORdO0qmYb8uvGpuFAfVp31OMDDnEecVronNAHt4Q4ZRp7uhtszlUf0ximHbVdGMJyoHbydP59yMHZgebl6Vz4oy-_Ji97O2R887gvyY8vN9-v76r7b7dfr6_uK9eAWCrdM933Wsu688zL2vuuF762tQLBOetZI5X1THWtZ-A8b7V3jZSiUcCsbFBckg8nb_6L89qZOYXRpoOJNpjP4eeViWln1tVwqJngBX9_wucU_6yYFzOG7HAY7IRxzYaJWpfk2loUlJ9Ql2LOCftnNwNz7MDszbEDc-zAQBkmy9O7R__ajeifX55CL8CnE4AllIeAyWQXcHIl8YRuMT6G__n_AR51mtM
CitedBy_id crossref_primary_10_1016_j_ejps_2021_105860
crossref_primary_10_1016_j_xphs_2018_11_006
crossref_primary_10_1146_annurev_chembioeng_060718_030304
crossref_primary_10_3390_pharmaceutics11090425
crossref_primary_10_1021_acs_molpharmaceut_8b00725
crossref_primary_10_1016_j_ejps_2019_105091
crossref_primary_10_1016_j_jsps_2019_03_004
crossref_primary_10_1021_mp4004145
crossref_primary_10_1016_j_jconrel_2023_01_019
crossref_primary_10_1016_j_xphs_2017_10_003
crossref_primary_10_1016_j_ijpharm_2023_123536
crossref_primary_10_1002_jps_24541
crossref_primary_10_1021_acs_molpharmaceut_5b00409
crossref_primary_10_1016_j_addr_2022_114468
crossref_primary_10_3390_molecules29112609
crossref_primary_10_3390_pharmaceutics10020060
crossref_primary_10_1021_acs_molpharmaceut_8b01229
crossref_primary_10_1002_cptc_202200134
crossref_primary_10_1021_acs_molpharmaceut_8b00699
crossref_primary_10_1039_C9ME00109C
crossref_primary_10_1007_s11095_017_2174_7
crossref_primary_10_1080_14787210_2019_1675508
crossref_primary_10_1016_j_xphs_2016_07_031
crossref_primary_10_1016_j_ijpharm_2020_119489
crossref_primary_10_1016_j_xphs_2016_03_014
crossref_primary_10_1111_jphp_12984
crossref_primary_10_1080_10837450_2019_1616208
crossref_primary_10_1007_s11095_018_2408_3
crossref_primary_10_1016_j_ejpb_2020_04_017
crossref_primary_10_1016_j_ijpharm_2015_08_101
crossref_primary_10_1016_j_jddst_2019_02_019
crossref_primary_10_1021_acs_molpharmaceut_6b00650
crossref_primary_10_1016_j_xphs_2017_06_012
crossref_primary_10_1021_acs_molpharmaceut_8b00021
crossref_primary_10_4155_tde_15_45
crossref_primary_10_1016_j_ijpharm_2021_120492
crossref_primary_10_3390_pharmaceutics13111926
crossref_primary_10_4155_tde_14_39
crossref_primary_10_1016_j_xphs_2020_08_008
crossref_primary_10_3390_pharmaceutics11060268
crossref_primary_10_1016_j_apt_2018_04_002
crossref_primary_10_3109_03639045_2016_1160105
crossref_primary_10_1016_j_ijpharm_2021_120649
crossref_primary_10_1021_acs_molpharmaceut_5b00351
crossref_primary_10_1021_mp500303a
crossref_primary_10_1016_j_ejpb_2018_01_013
crossref_primary_10_1016_j_xphs_2018_03_029
crossref_primary_10_1021_acs_cgd_0c00770
crossref_primary_10_1007_s10953_015_0410_5
crossref_primary_10_1016_j_xphs_2017_03_029
crossref_primary_10_3390_pharmaceutics12121209
crossref_primary_10_1063_5_0156222
crossref_primary_10_1080_17425247_2017_1321634
crossref_primary_10_1016_j_addr_2017_03_002
crossref_primary_10_1016_j_jddst_2023_104290
crossref_primary_10_3109_03639045_2015_1075033
crossref_primary_10_3390_ph13080182
crossref_primary_10_1016_j_jsps_2016_09_013
crossref_primary_10_1016_j_ejpb_2018_11_016
crossref_primary_10_1021_ci5004834
crossref_primary_10_1039_D0CE00070A
crossref_primary_10_1016_j_addr_2016_02_005
crossref_primary_10_1016_j_ejps_2024_106780
crossref_primary_10_1155_2022_5916013
crossref_primary_10_1016_j_xphs_2022_11_004
crossref_primary_10_3109_10717544_2014_993747
crossref_primary_10_1016_j_xphs_2016_05_024
crossref_primary_10_1021_acsomega_2c08146
crossref_primary_10_1016_j_ijpharm_2018_09_059
crossref_primary_10_1016_j_ejps_2013_10_015
crossref_primary_10_1021_acs_nanolett_2c01608
crossref_primary_10_1016_j_ijpharm_2020_119545
crossref_primary_10_1063_1_4947476
crossref_primary_10_1021_acs_cgd_1c00997
crossref_primary_10_1021_acs_molpharmaceut_5b00688
crossref_primary_10_1021_acs_molpharmaceut_2c00339
crossref_primary_10_1021_acs_joc_0c01014
crossref_primary_10_1016_j_ejps_2015_08_006
crossref_primary_10_1016_j_xphs_2015_10_008
crossref_primary_10_1039_C9RA08441J
crossref_primary_10_14356_kona_2025008
crossref_primary_10_3390_pharmaceutics11050202
crossref_primary_10_1016_j_ijpharm_2022_121784
crossref_primary_10_1039_D1CE01327K
crossref_primary_10_1016_j_xphs_2018_04_028
crossref_primary_10_1021_acs_molpharmaceut_0c00355
crossref_primary_10_3390_pharmaceutics11100529
crossref_primary_10_1016_j_xphs_2017_09_024
crossref_primary_10_1021_acs_molpharmaceut_1c00783
Cites_doi 10.1002/jps.21162
10.1023/A:1007516718048
10.1016/j.ijpharm.2011.08.032
10.1016/j.ijpharm.2009.12.009
10.1021/jp110975y
10.1016/0378-5173(92)90137-Q
10.1063/1.3216109
10.1063/1.3586805
10.1016/0001-6160(79)90076-2
10.1007/s11095-010-0129-3
10.1002/jps.22232
10.1023/A:1016292416526
10.1016/j.ijpharm.2012.04.066
10.1016/j.ejpb.2008.07.010
10.1002/jps.21138
10.1002/jps.22214
10.1016/j.ejps.2009.04.005
10.1002/jps.21728
10.1016/j.ejps.2007.06.005
10.1021/jp0700027
10.1023/B:PHAM.0000033003.17251.c3
10.1002/jps.1033
10.1021/cr60135a002
10.1021/mp100339c
10.1002/jps.22197
10.1021/mp3000698
10.1016/j.ijpharm.2004.01.005
10.1021/js9601896
10.1002/jps.10169
10.1007/s11095-006-9047-9
10.1002/jps.21647
10.1007/s11095-006-9023-4
10.1021/la052367t
10.1080/00107516908204405
10.1021/jp7113384
10.1007/s11095-010-0269-5
ContentType Journal Article
Copyright 2013 Elsevier B.V.
Copyright © 2013 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2013 Elsevier B.V.
– notice: Copyright © 2013 Elsevier B.V. All rights reserved.
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ACNBI
ADTPV
AOWAS
D8T
DF2
ZZAVC
DOI 10.1016/j.ejps.2013.03.016
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
SWEPUB Uppsala universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Uppsala universitet
SwePub Articles full text
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1879-0720
EndPage 332
ExternalDocumentID oai_DiVA_org_uu_204132
10_1016_j_ejps_2013_03_016
23557841
S0928098713001243
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
6I.
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATCM
AAXUO
ABFRF
ABJNI
ABLJU
ABMAC
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
GROUPED_DOAJ
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSP
SSZ
T5K
TEORI
~G-
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
29G
AAQXK
AAYXX
ABFNM
ADMUD
ADVLN
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
G-2
HMT
HVGLF
HZ~
OK1
R2-
SEW
SPT
WUQ
7X8
0SF
ACNBI
ADTPV
AOWAS
D8T
DF2
ZZAVC
ID FETCH-LOGICAL-c503t-9f19ff9964bd1d64ddbf3d4a4803221f1568ad18b7d10cd279dc56635801a65e3
ISSN 0928-0987
1879-0720
IngestDate Tue Oct 01 22:14:21 EDT 2024
Fri Oct 25 03:52:12 EDT 2024
Thu Nov 21 22:31:26 EST 2024
Sat Sep 28 08:01:38 EDT 2024
Fri Feb 23 02:19:36 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Amorphous stability
Glass-forming ability
Glass transition temperature
Molecular weight
Prediction
Crystallization temperature
Language English
License http://creativecommons.org/licenses/by-nc-nd/3.0
Copyright © 2013 Elsevier B.V. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c503t-9f19ff9964bd1d64ddbf3d4a4803221f1568ad18b7d10cd279dc56635801a65e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-204132
PMID 23557841
PQID 1349092743
PQPubID 23479
PageCount 10
ParticipantIDs swepub_primary_oai_DiVA_org_uu_204132
proquest_miscellaneous_1349092743
crossref_primary_10_1016_j_ejps_2013_03_016
pubmed_primary_23557841
elsevier_sciencedirect_doi_10_1016_j_ejps_2013_03_016
PublicationCentury 2000
PublicationDate 2013-05-13
PublicationDateYYYYMMDD 2013-05-13
PublicationDate_xml – month: 05
  year: 2013
  text: 2013-05-13
  day: 13
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle European journal of pharmaceutical sciences
PublicationTitleAlternate Eur J Pharm Sci
PublicationYear 2013
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Kearns, Swallen, Ediger, Wu, Sun, Yu (b0080) 2008; 112
Stukalin, Douglas, Freed (b0195) 2009; 131
Bhugra, Pikal (b0025) 2008; 97
Lindfors, Forssen, Skantze, Skantze, Zackrisson, Olsson (b0095) 2006; 22
Hancock, Shamblin, Zografi (b0065) 1995; 12
Branchu, Roqueda, Plumb, Cook (b0035) 2007; 32
Hancock, Parks (b0055) 2000; 17
Laitinen, R., Löbmann, K., Strachan, C.J., Grohganz, H., Rades, T., 2012. Emerging trends in the stabilization of amorphous drugs. International Journal of Pharmaceutics, in press.
Xiang, Anderson (b0170) 2013; 10
Ziffels, Steckel (b0190) 2010; 387
Thompson, Spaepen (b0140) 1979; 27
Zhou, Zhang, Law, Grant, Schmitt (b0185) 2002; 91
Bhugra, Shmeis, Krill, Pikal (b0030) 2008; 97
Turnbull (b0150) 1969; 10
Aso, Yoshioka, Kojima (b0005) 2001; 90
Bhattacharya, Suryanarayanan (b0015) 2009; 98
Surana, Pyne, Suryanarayanan (b0135) 2004; 21
Baird, Van Eerdenbrugh, Taylor (b0010) 2010; 99
Wu, Yu (b0165) 2006; V23
Yamaguchi, Nishimura, Okamoto, Takeuchi, Yamamoto (b0175) 1992; 85
Murdande, Pikal, Shanker, Bogner (b0110) 2010; 27
Schoug, Mahlin, Jonson, Håkansson (b0120) 2009; 99
Kauzmann (b0070) 1948; 43
Singh, de Pablo (b0125) 2011; 134
Mahlin, Ponnambalam, Heidarian Höckerfelt, Bergström (b0100) 2011; 8
Trasi, Boerrigter, Byrn (b0145) 2010; 27
Hancock, Zograf (b0060) 1997; 86
Corrigan, Corrigan, Healy (b0045) 2004; 273
Lin, Cogdill, Wildfong (b0090) 2009; 98
Vyazovkin, Dranca (b0160) 2007; 111
Graeser, Patterson, Zeitler, Gordon, Rades (b0050) 2009; 37
Ping, Paraska, Baker, Harrowell, Angell (b0115) 2011; 115
Kawabata, Wada, Nakatani, Yamada, Onoue (b0075) 2011; 420
Van Eerdenbrugh, Baird, Taylor (b0155) 2010; 99
Zhang, Aaltonen, Tian, Saville, Rades (b0180) 2009; 71
Marsac, Konno, Taylor (b0105) 2006; 23
Caron, Bhugra, Pikal (b0040) 2010; 99
Singh (10.1016/j.ejps.2013.03.016_b0125) 2011; 134
Baird (10.1016/j.ejps.2013.03.016_b0010) 2010; 99
Wu (10.1016/j.ejps.2013.03.016_b0165) 2006; V23
Hancock (10.1016/j.ejps.2013.03.016_b0065) 1995; 12
10.1016/j.ejps.2013.03.016_b0085
Branchu (10.1016/j.ejps.2013.03.016_b0035) 2007; 32
Hancock (10.1016/j.ejps.2013.03.016_b0060) 1997; 86
Mahlin (10.1016/j.ejps.2013.03.016_b0100) 2011; 8
Kawabata (10.1016/j.ejps.2013.03.016_b0075) 2011; 420
Ping (10.1016/j.ejps.2013.03.016_b0115) 2011; 115
Bhugra (10.1016/j.ejps.2013.03.016_b0030) 2008; 97
Trasi (10.1016/j.ejps.2013.03.016_b0145) 2010; 27
Van Eerdenbrugh (10.1016/j.ejps.2013.03.016_b0155) 2010; 99
Murdande (10.1016/j.ejps.2013.03.016_b0110) 2010; 27
Turnbull (10.1016/j.ejps.2013.03.016_b0150) 1969; 10
Xiang (10.1016/j.ejps.2013.03.016_b0170) 2013; 10
Thompson (10.1016/j.ejps.2013.03.016_b0140) 1979; 27
Kearns (10.1016/j.ejps.2013.03.016_b0080) 2008; 112
Surana (10.1016/j.ejps.2013.03.016_b0135) 2004; 21
Zhang (10.1016/j.ejps.2013.03.016_b0180) 2009; 71
Lin (10.1016/j.ejps.2013.03.016_b0090) 2009; 98
Kauzmann (10.1016/j.ejps.2013.03.016_b0070) 1948; 43
Graeser (10.1016/j.ejps.2013.03.016_b0050) 2009; 37
Hancock (10.1016/j.ejps.2013.03.016_b0055) 2000; 17
Vyazovkin (10.1016/j.ejps.2013.03.016_b0160) 2007; 111
Bhattacharya (10.1016/j.ejps.2013.03.016_b0015) 2009; 98
Aso (10.1016/j.ejps.2013.03.016_b0005) 2001; 90
Lindfors (10.1016/j.ejps.2013.03.016_b0095) 2006; 22
Marsac (10.1016/j.ejps.2013.03.016_b0105) 2006; 23
Stukalin (10.1016/j.ejps.2013.03.016_b0195) 2009; 131
Yamaguchi (10.1016/j.ejps.2013.03.016_b0175) 1992; 85
Corrigan (10.1016/j.ejps.2013.03.016_b0045) 2004; 273
Schoug (10.1016/j.ejps.2013.03.016_b0120) 2009; 99
Bhugra (10.1016/j.ejps.2013.03.016_b0025) 2008; 97
Caron (10.1016/j.ejps.2013.03.016_b0040) 2010; 99
Zhou (10.1016/j.ejps.2013.03.016_b0185) 2002; 91
Ziffels (10.1016/j.ejps.2013.03.016_b0190) 2010; 387
References_xml – volume: 90
  start-page: 798
  year: 2001
  end-page: 806
  ident: b0005
  article-title: Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by C-13 nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperature
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Kojima
– volume: 8
  start-page: 498
  year: 2011
  end-page: 506
  ident: b0100
  article-title: Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development
  publication-title: Molecular Pharmaceutics
  contributor:
    fullname: Bergström
– volume: 131
  start-page: 114905
  year: 2009
  ident: b0195
  article-title: Application of the entropy theory of glass formation to poly(alpha-olefins)
  publication-title: Journal of Chemical Physics
  contributor:
    fullname: Freed
– volume: 98
  start-page: 2935
  year: 2009
  end-page: 2953
  ident: b0015
  article-title: Local mobility in amorphous pharmaceuticals–characterization and implications on stability
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Suryanarayanan
– volume: 97
  start-page: 1329
  year: 2008
  end-page: 1349
  ident: b0025
  article-title: Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Pikal
– volume: 97
  start-page: 455
  year: 2008
  end-page: 472
  ident: b0030
  article-title: Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Pikal
– volume: 23
  start-page: 2306
  year: 2006
  end-page: 2316
  ident: b0105
  article-title: A comparison of the physical stability of amorphous felodipine and nifedipine systems
  publication-title: Pharmaceutical Research
  contributor:
    fullname: Taylor
– volume: 10
  start-page: 102
  year: 2013
  end-page: 114
  ident: b0170
  article-title: Molecular dynamics simulation of amorphous indomethacin
  publication-title: Molecular Pharmaceutics
  contributor:
    fullname: Anderson
– volume: 111
  start-page: 7283
  year: 2007
  end-page: 7287
  ident: b0160
  article-title: Effect of physical aging on nucleation of amorphous indomethacin
  publication-title: Journal of Physical Chemistry B
  contributor:
    fullname: Dranca
– volume: 32
  start-page: 128
  year: 2007
  end-page: 139
  ident: b0035
  article-title: A decision-support tool for the formulation of orally active, poorly soluble compounds
  publication-title: European Journal of Pharmaceutical Sciences
  contributor:
    fullname: Cook
– volume: V23
  start-page: 2350
  year: 2006
  end-page: 2355
  ident: b0165
  article-title: Surface crystallization of indomethacin below Tg
  publication-title: Pharmaceutical Research
  contributor:
    fullname: Yu
– volume: 91
  start-page: 1863
  year: 2002
  end-page: 1872
  ident: b0185
  article-title: Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Schmitt
– volume: 17
  start-page: 397
  year: 2000
  end-page: 404
  ident: b0055
  article-title: What is the true solubility advantage for amorphous pharmaceuticals?
  publication-title: Pharmaceutical Research
  contributor:
    fullname: Parks
– volume: 27
  start-page: 1377
  year: 2010
  end-page: 1389
  ident: b0145
  article-title: Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin
  publication-title: Pharmaceutical Research
  contributor:
    fullname: Byrn
– volume: 27
  start-page: 1855
  year: 1979
  end-page: 1859
  ident: b0140
  article-title: On the approximation of the free energy change on crystallization
  publication-title: Acta Metallurgica
  contributor:
    fullname: Spaepen
– volume: 99
  start-page: 3826
  year: 2010
  end-page: 3838
  ident: b0155
  article-title: Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation–classification and comparison with crystallization tendency from undercooled melts
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Taylor
– volume: 420
  start-page: 1
  year: 2011
  end-page: 10
  ident: b0075
  article-title: Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications
  publication-title: International Journal of Pharmaceutics
  contributor:
    fullname: Onoue
– volume: 22
  start-page: 911
  year: 2006
  end-page: 916
  ident: b0095
  article-title: Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations
  publication-title: Langmuir
  contributor:
    fullname: Olsson
– volume: 10
  start-page: 473
  year: 1969
  end-page: 488
  ident: b0150
  article-title: Under what conditions can a glass be formed?
  publication-title: Contemporary Physics
  contributor:
    fullname: Turnbull
– volume: 12
  start-page: 799
  year: 1995
  end-page: 806
  ident: b0065
  article-title: Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperatures
  publication-title: Pharmaceutical Research
  contributor:
    fullname: Zografi
– volume: 21
  start-page: 1167
  year: 2004
  end-page: 1176
  ident: b0135
  article-title: Effect of preparation method on physical properties of amorphous trehalose
  publication-title: Pharmaceutical Research
  contributor:
    fullname: Suryanarayanan
– volume: 134
  start-page: 194903
  year: 2011
  end-page: 194907
  ident: b0125
  article-title: A molecular view of vapor deposited glasses
  publication-title: The Journal of Chemical Physics
  contributor:
    fullname: de Pablo
– volume: 112
  start-page: 4934
  year: 2008
  end-page: 4942
  ident: b0080
  article-title: Hiking down the energy landscape: progress toward the Kauzmann temperature via vapor deposition
  publication-title: Journal of Physical Chemistry B
  contributor:
    fullname: Yu
– volume: 99
  start-page: 2032
  year: 2009
  end-page: 2048
  ident: b0120
  article-title: Differential effects of polymers PVP90 and Ficoll400 on storage stability and viability of
  publication-title: Journal of Applied Microbiology
  contributor:
    fullname: Håkansson
– volume: 71
  start-page: 64
  year: 2009
  end-page: 70
  ident: b0180
  article-title: Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin
  publication-title: European Journal of Pharmaceutics and Biopharmaceutics
  contributor:
    fullname: Rades
– volume: 86
  start-page: 1
  year: 1997
  end-page: 12
  ident: b0060
  article-title: Characteristics and significance of the amorphous state in pharmaceutical systems
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Zograf
– volume: 98
  start-page: 2696
  year: 2009
  end-page: 2708
  ident: b0090
  article-title: Informatic calibration of a materials properties database for predictive assessment of mechanically activated disordering potential for small molecule organic solids
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Wildfong
– volume: 27
  start-page: 2704
  year: 2010
  end-page: 2714
  ident: b0110
  article-title: Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals
  publication-title: Pharmaceutical Research
  contributor:
    fullname: Bogner
– volume: 115
  start-page: 4696
  year: 2011
  end-page: 4702
  ident: b0115
  article-title: Molecular engineering of the glass transition: glass-forming ability across a homologous series of cyclic stilbenes
  publication-title: The Journal of Physical Chemistry B
  contributor:
    fullname: Angell
– volume: 273
  start-page: 171
  year: 2004
  end-page: 182
  ident: b0045
  article-title: Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems
  publication-title: International Journal of Pharmaceutics
  contributor:
    fullname: Healy
– volume: 85
  start-page: 87
  year: 1992
  end-page: 96
  ident: b0175
  article-title: Glass-formation of 4′′-O-(4-methoxyphenyl)acetyltylosin and physicochemical stability of the amorphous solid
  publication-title: International Journal of Pharmaceutics
  contributor:
    fullname: Yamamoto
– volume: 99
  start-page: 3787
  year: 2010
  end-page: 3806
  ident: b0010
  article-title: A classification system to assess the crystallization tendency of organic molecules from undercooled melts
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Taylor
– volume: 37
  start-page: 492
  year: 2009
  end-page: 498
  ident: b0050
  article-title: Correlating thermodynamic and kinetic parameters with amorphous stability
  publication-title: European Journal of Pharmaceutical Sciences
  contributor:
    fullname: Rades
– volume: 99
  start-page: 3887
  year: 2010
  end-page: 3900
  ident: b0040
  article-title: Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP
  publication-title: Journal of Pharmaceutical Sciences
  contributor:
    fullname: Pikal
– volume: 387
  start-page: 71
  year: 2010
  end-page: 78
  ident: b0190
  article-title: Influence of amorphous content on compaction behaviour of anhydrous [alpha]-lactose
  publication-title: International Journal of Pharmaceutics
  contributor:
    fullname: Steckel
– volume: 43
  start-page: 219
  year: 1948
  end-page: 256
  ident: b0070
  article-title: The nature of the glassy state and the behavior of liquids at low temperatures
  publication-title: Chemical Reviews
  contributor:
    fullname: Kauzmann
– volume: 97
  start-page: 455
  year: 2008
  ident: 10.1016/j.ejps.2013.03.016_b0030
  article-title: Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1002/jps.21162
  contributor:
    fullname: Bhugra
– volume: 17
  start-page: 397
  year: 2000
  ident: 10.1016/j.ejps.2013.03.016_b0055
  article-title: What is the true solubility advantage for amorphous pharmaceuticals?
  publication-title: Pharmaceutical Research
  doi: 10.1023/A:1007516718048
  contributor:
    fullname: Hancock
– volume: 420
  start-page: 1
  year: 2011
  ident: 10.1016/j.ejps.2013.03.016_b0075
  article-title: Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications
  publication-title: International Journal of Pharmaceutics
  doi: 10.1016/j.ijpharm.2011.08.032
  contributor:
    fullname: Kawabata
– volume: 387
  start-page: 71
  year: 2010
  ident: 10.1016/j.ejps.2013.03.016_b0190
  article-title: Influence of amorphous content on compaction behaviour of anhydrous [alpha]-lactose
  publication-title: International Journal of Pharmaceutics
  doi: 10.1016/j.ijpharm.2009.12.009
  contributor:
    fullname: Ziffels
– volume: 115
  start-page: 4696
  year: 2011
  ident: 10.1016/j.ejps.2013.03.016_b0115
  article-title: Molecular engineering of the glass transition: glass-forming ability across a homologous series of cyclic stilbenes
  publication-title: The Journal of Physical Chemistry B
  doi: 10.1021/jp110975y
  contributor:
    fullname: Ping
– volume: 85
  start-page: 87
  year: 1992
  ident: 10.1016/j.ejps.2013.03.016_b0175
  article-title: Glass-formation of 4′′-O-(4-methoxyphenyl)acetyltylosin and physicochemical stability of the amorphous solid
  publication-title: International Journal of Pharmaceutics
  doi: 10.1016/0378-5173(92)90137-Q
  contributor:
    fullname: Yamaguchi
– volume: 131
  start-page: 114905
  year: 2009
  ident: 10.1016/j.ejps.2013.03.016_b0195
  article-title: Application of the entropy theory of glass formation to poly(alpha-olefins)
  publication-title: Journal of Chemical Physics
  doi: 10.1063/1.3216109
  contributor:
    fullname: Stukalin
– volume: 134
  start-page: 194903
  year: 2011
  ident: 10.1016/j.ejps.2013.03.016_b0125
  article-title: A molecular view of vapor deposited glasses
  publication-title: The Journal of Chemical Physics
  doi: 10.1063/1.3586805
  contributor:
    fullname: Singh
– volume: 27
  start-page: 1855
  year: 1979
  ident: 10.1016/j.ejps.2013.03.016_b0140
  article-title: On the approximation of the free energy change on crystallization
  publication-title: Acta Metallurgica
  doi: 10.1016/0001-6160(79)90076-2
  contributor:
    fullname: Thompson
– volume: 27
  start-page: 1377
  year: 2010
  ident: 10.1016/j.ejps.2013.03.016_b0145
  article-title: Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin
  publication-title: Pharmaceutical Research
  doi: 10.1007/s11095-010-0129-3
  contributor:
    fullname: Trasi
– volume: 99
  start-page: 3887
  year: 2010
  ident: 10.1016/j.ejps.2013.03.016_b0040
  article-title: Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1002/jps.22232
  contributor:
    fullname: Caron
– volume: 12
  start-page: 799
  year: 1995
  ident: 10.1016/j.ejps.2013.03.016_b0065
  article-title: Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperatures
  publication-title: Pharmaceutical Research
  doi: 10.1023/A:1016292416526
  contributor:
    fullname: Hancock
– ident: 10.1016/j.ejps.2013.03.016_b0085
  doi: 10.1016/j.ijpharm.2012.04.066
– volume: 71
  start-page: 64
  year: 2009
  ident: 10.1016/j.ejps.2013.03.016_b0180
  article-title: Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin
  publication-title: European Journal of Pharmaceutics and Biopharmaceutics
  doi: 10.1016/j.ejpb.2008.07.010
  contributor:
    fullname: Zhang
– volume: 97
  start-page: 1329
  year: 2008
  ident: 10.1016/j.ejps.2013.03.016_b0025
  article-title: Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1002/jps.21138
  contributor:
    fullname: Bhugra
– volume: 99
  start-page: 3826
  year: 2010
  ident: 10.1016/j.ejps.2013.03.016_b0155
  article-title: Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation–classification and comparison with crystallization tendency from undercooled melts
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1002/jps.22214
  contributor:
    fullname: Van Eerdenbrugh
– volume: 37
  start-page: 492
  year: 2009
  ident: 10.1016/j.ejps.2013.03.016_b0050
  article-title: Correlating thermodynamic and kinetic parameters with amorphous stability
  publication-title: European Journal of Pharmaceutical Sciences
  doi: 10.1016/j.ejps.2009.04.005
  contributor:
    fullname: Graeser
– volume: 98
  start-page: 2935
  year: 2009
  ident: 10.1016/j.ejps.2013.03.016_b0015
  article-title: Local mobility in amorphous pharmaceuticals–characterization and implications on stability
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1002/jps.21728
  contributor:
    fullname: Bhattacharya
– volume: 32
  start-page: 128
  year: 2007
  ident: 10.1016/j.ejps.2013.03.016_b0035
  article-title: A decision-support tool for the formulation of orally active, poorly soluble compounds
  publication-title: European Journal of Pharmaceutical Sciences
  doi: 10.1016/j.ejps.2007.06.005
  contributor:
    fullname: Branchu
– volume: 111
  start-page: 7283
  year: 2007
  ident: 10.1016/j.ejps.2013.03.016_b0160
  article-title: Effect of physical aging on nucleation of amorphous indomethacin
  publication-title: Journal of Physical Chemistry B
  doi: 10.1021/jp0700027
  contributor:
    fullname: Vyazovkin
– volume: 21
  start-page: 1167
  year: 2004
  ident: 10.1016/j.ejps.2013.03.016_b0135
  article-title: Effect of preparation method on physical properties of amorphous trehalose
  publication-title: Pharmaceutical Research
  doi: 10.1023/B:PHAM.0000033003.17251.c3
  contributor:
    fullname: Surana
– volume: 90
  start-page: 798
  year: 2001
  ident: 10.1016/j.ejps.2013.03.016_b0005
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1002/jps.1033
  contributor:
    fullname: Aso
– volume: 43
  start-page: 219
  year: 1948
  ident: 10.1016/j.ejps.2013.03.016_b0070
  article-title: The nature of the glassy state and the behavior of liquids at low temperatures
  publication-title: Chemical Reviews
  doi: 10.1021/cr60135a002
  contributor:
    fullname: Kauzmann
– volume: 8
  start-page: 498
  year: 2011
  ident: 10.1016/j.ejps.2013.03.016_b0100
  article-title: Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development
  publication-title: Molecular Pharmaceutics
  doi: 10.1021/mp100339c
  contributor:
    fullname: Mahlin
– volume: 99
  start-page: 3787
  year: 2010
  ident: 10.1016/j.ejps.2013.03.016_b0010
  article-title: A classification system to assess the crystallization tendency of organic molecules from undercooled melts
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1002/jps.22197
  contributor:
    fullname: Baird
– volume: 10
  start-page: 102
  year: 2013
  ident: 10.1016/j.ejps.2013.03.016_b0170
  article-title: Molecular dynamics simulation of amorphous indomethacin
  publication-title: Molecular Pharmaceutics
  doi: 10.1021/mp3000698
  contributor:
    fullname: Xiang
– volume: 273
  start-page: 171
  year: 2004
  ident: 10.1016/j.ejps.2013.03.016_b0045
  article-title: Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems
  publication-title: International Journal of Pharmaceutics
  doi: 10.1016/j.ijpharm.2004.01.005
  contributor:
    fullname: Corrigan
– volume: 86
  start-page: 1
  year: 1997
  ident: 10.1016/j.ejps.2013.03.016_b0060
  article-title: Characteristics and significance of the amorphous state in pharmaceutical systems
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1021/js9601896
  contributor:
    fullname: Hancock
– volume: 91
  start-page: 1863
  year: 2002
  ident: 10.1016/j.ejps.2013.03.016_b0185
  article-title: Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1002/jps.10169
  contributor:
    fullname: Zhou
– volume: 23
  start-page: 2306
  year: 2006
  ident: 10.1016/j.ejps.2013.03.016_b0105
  article-title: A comparison of the physical stability of amorphous felodipine and nifedipine systems
  publication-title: Pharmaceutical Research
  doi: 10.1007/s11095-006-9047-9
  contributor:
    fullname: Marsac
– volume: 99
  start-page: 2032
  year: 2009
  ident: 10.1016/j.ejps.2013.03.016_b0120
  article-title: Differential effects of polymers PVP90 and Ficoll400 on storage stability and viability of Lactobacillus coryniformis Si3 freeze-dried in sucrose
  publication-title: Journal of Applied Microbiology
  contributor:
    fullname: Schoug
– volume: 98
  start-page: 2696
  year: 2009
  ident: 10.1016/j.ejps.2013.03.016_b0090
  article-title: Informatic calibration of a materials properties database for predictive assessment of mechanically activated disordering potential for small molecule organic solids
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1002/jps.21647
  contributor:
    fullname: Lin
– volume: V23
  start-page: 2350
  year: 2006
  ident: 10.1016/j.ejps.2013.03.016_b0165
  article-title: Surface crystallization of indomethacin below Tg
  publication-title: Pharmaceutical Research
  doi: 10.1007/s11095-006-9023-4
  contributor:
    fullname: Wu
– volume: 22
  start-page: 911
  year: 2006
  ident: 10.1016/j.ejps.2013.03.016_b0095
  article-title: Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations
  publication-title: Langmuir
  doi: 10.1021/la052367t
  contributor:
    fullname: Lindfors
– volume: 10
  start-page: 473
  year: 1969
  ident: 10.1016/j.ejps.2013.03.016_b0150
  article-title: Under what conditions can a glass be formed?
  publication-title: Contemporary Physics
  doi: 10.1080/00107516908204405
  contributor:
    fullname: Turnbull
– volume: 112
  start-page: 4934
  year: 2008
  ident: 10.1016/j.ejps.2013.03.016_b0080
  article-title: Hiking down the energy landscape: progress toward the Kauzmann temperature via vapor deposition
  publication-title: Journal of Physical Chemistry B
  doi: 10.1021/jp7113384
  contributor:
    fullname: Kearns
– volume: 27
  start-page: 2704
  year: 2010
  ident: 10.1016/j.ejps.2013.03.016_b0110
  article-title: Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals
  publication-title: Pharmaceutical Research
  doi: 10.1007/s11095-010-0269-5
  contributor:
    fullname: Murdande
SSID ssj0006870
Score 2.4345896
Snippet The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A...
SourceID swepub
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 323
SubjectTerms Amorphous stability
Calorimetry, Differential Scanning
Crystallization temperature
Drug Compounding
Drug Stability
Glass - chemistry
Glass transition temperature
Glass-forming ability
Models, Chemical
Molecular weight
Pharmaceutical Preparations - chemistry
Powder Diffraction
Prediction
Transition Temperature
X-Ray Diffraction
Title Early drug development predictions of glass-forming ability and physical stability of drugs
URI https://dx.doi.org/10.1016/j.ejps.2013.03.016
https://www.ncbi.nlm.nih.gov/pubmed/23557841
https://search.proquest.com/docview/1349092743
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-204132
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa67YUXxJ0yQEaCvbBUcW5NHwsrGjygSS1oEg-WE9tllUirpHnYv985tnNZqyFAQqqiyk0TN9_Xcz4f-xwT8tb3MyHzJPAkuDMv0lp5kygQXixAbqS5EEJhwO18Pv56mZ7Notlg0CwW7tr-K9LQBlhj5uxfoN1eFBrgPWAOR0Adjn-Eu61YLMt62SREmen-TYkzMu2yNyOaPRSsJknRrJC1lZg2DXAgG10znI_Xq-6M4jtFu_l5Kz7unGsr2nGn5Stn5IqiS6RQ5bLamhn7D8mvruCBAu6M5qN-WIKZRYA2q9TGyvbyZWzQEethT5yLVdbkpmNMowr8vk22ZUwd94KegQ1tdrLz1aGNje65ARuRWI3UaoMl2VloCtmynZrbxovPsU_YJZzXA7ETHpCjAIwW2Myj6efZ5ZfWryep2Xqw_Q0uBcuuFty9010yZ38Ys1Oj1uiaxQNy3w1I6NQy6SEZqOIRObmwUF6f0kWXoFed0hN60dU6v35Mfhi6UaQH7dGN9uhG15reoht1vKJAN9rQjbZ0w_MN3Z6Qb59mi4_nntuvw8tjP9x6E80mWsMAOsokk0kkZaZDGYko9cFtMM3iJBWSpdlYMj-X8JRlHqPiBZUkkliFT8lhsS7Uc0KlHAdhqOIgjzQMKWBckGFgIdRJnOFM8pC8bx4v39iyLLxZr7jiCAZHMLgPL5YMSdwgwB33rWDkQJjffu9NAxcHq4tTaaJQ67riWNQTiADye0ieWRzbfgQg4XE2f0jeWWDbT7CU-9nV9ylfl0te13ArkJDBi3_s3TG51_3xXpLDbVmrV-SgkvVrR90bwr6-4A
link.rule.ids 230,315,782,786,887,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+drug+development+predictions+of+glass-forming+ability+and+physical+stability+of+drugs&rft.jtitle=European+journal+of+pharmaceutical+sciences&rft.au=Mahlin%2C+Denny&rft.au=Bergstr%C3%B6m%2C+Christel+A.S.&rft.date=2013-05-13&rft.pub=Elsevier+B.V&rft.issn=0928-0987&rft.eissn=1879-0720&rft.volume=49&rft.issue=2&rft.spage=323&rft.epage=332&rft_id=info:doi/10.1016%2Fj.ejps.2013.03.016&rft.externalDocID=S0928098713001243
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0928-0987&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0928-0987&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0928-0987&client=summon